Enthesitis is an entry criterion of the ClASsification criteria for Psoriatic ARthritis (CASPAR) criteria (1) . It is an inflammation of tendon, ligament, or joint capsule insertion, with an estimated prevalence of 25-78% (2) . The presentation is similar to other tendon complaints that are quite common in the healthy population (3) . Therefore, general practitioners, dermatologists, and rheumatologists do not always recognize the presence of enthesitis or its association with psoriatic arthritis (PsA) (2) .
In research, enthesitis is scored by counting the number of tender entheses. Tenderness does not occur in inflammatory enthesiopathy alone (4, 5) . Other means may help to differentiate inflammatory from non-inflammatory entheseal tenderness. Ultrasound can be used to investigate multiple superficially located entheses. Abnormalities can be quantified with a combined score, for example the MAdrid Sonographic Enthesitis Index (MASEI) (6) .
The main objective of this cross-sectional study was to investigate the frequency of ultrasound changes at the entheses of patients with recently diagnosed PsA, patients with established PsA, and young healthy volunteers (aged 20-30 years). In this extreme comparison, we aimed to describe sonographic signs of enthesitis in clearly diseased and clearly non-diseased entheses. The secondary objective was to investigate whether an enthesitis score (using the MASEI) was able to distinguish between the three groups. We chose a control group of young healthy volunteers because their tendons have matured but have had limited exposure to the other causes of enthesiopathy.
Method

Patients and setting
Three groups of participants were investigated: new PsA patients, established PsA patients and healthy volunteers (aged 20-30 years). Consecutive newly diagnosed and established patients were included in hospitals in the south-west of the Netherlands. Established disease was defined as having been diagnosed with PsA for at least 2 years. Those patients were included irrespective of disease activity. To reduce the impact of age on ultrasound readings and clinical evaluation, an age limit of 55 years was set in the established PsA group. Healthy 20-30-year-old volunteers were recruited via advertisement at the medical faculty and by word of mouth. Exclusion criteria for healthy volunteers were familiar hypercholesterolaemia, diabetes mellitus, and having any rheumatological disease. Participants were recruited from May 2015 to January 2016. Written informed consent was obtained from all participants according to the Declaration of Helsinki. The study was approved by the local medical research ethics committee of Erasmus MC, University Medical Center Rotterdam, the Netherlands (MEC-2012-549).
Data collection
Ultrasound examination of the entheses was performed by a trained sonographer (KW) who was blinded to the clinical information. An Esaote MyLab60 with the Probe LA-435 (6-18 MHz; Doppler frequency of 8.3 MHz, pulse repetition frequency of 750 Hz, and a wall filter of 3) and Probe LA-523 (4-13 MHz; 6.3 MHz, 750 Hz, and a wall filter of 4) was used. A colour gain was set at the disappearance of colour noise in the bone underneath the enthesis. The six MASEI locations and the common extensor insertion at the lateral epicondyle of the elbow [increased thickness cut-off 4.2 mm (7)] were assessed bilaterally. Each ultrasound location was scored for calcifications, erosions, increased thickness, structure, power Doppler (PD) signal, and bursitis, in accordance with the MASEI (6).
Positioning of patients followed the recommendations of the MASEI developers, but with the knee flexed at approximately 30°instead of 70°to improve PD signal detection (8) . The lateral epicondyle was examined in 90°elbow flexion. PD was scored with a semi-quantitative scoring system similar to the method used in arthritis (9): 0, absent; 1, one colour spot; 1.5, two colour spots; 2, confluent signal; and 3, severe signal (Supplementary Figure S1 ). Interrater agreement of rescoring was 93% and the weighted Cohen's kappa with linear weights was 0.92.
Statistical methods
Simple descriptive techniques fitting the distribution were used to describe the study results and determine whether ultrasound data differed in the three groups, in STATA 14.0.
Results
Participants
In total, 75 participants were evaluated: 25 new PsA and 25 established PsA patients, and 25 young healthy volunteers. Median disease duration was 2.9 weeks in new PsA and 8.0 years in established PsA (Table 1) . Median symptom duration of musculoskeletal complaints as reported by the new patients was 1.2 years [interquartile range (IQR) 0.6-3.1 years].
Structural ultrasound findings
Calcifications were seen in all locations of entheses in patients, with the highest prevalence at the lateral epicondyle (entheses of new 56% vs established 28%), quadriceps tendon (68% vs 50%), and Achilles tendon (70% vs 56%) ( Table 2 and Supplementary Table S1 ). In entheses of healthy volunteers, calcifications were seen far less frequently and they mainly occurred in the quadriceps tendon (30%). Increased thickness was seen at all locations in patient entheses, with the highest prevalence at the lateral epicondyle (entheses of new 80% vs established 74%) and at the knee entheses (prevalence range 52-82%). In healthy volunteers, only knee entheses had an increased thickness (range 50-70%).
Inflammatory ultrasound findings
The majority of patients and half of the healthy volunteers had a PD signal present in at least one enthesis (Table 3) . A PD score of 2 or more in at least one enthesis was present in 52% of new and 44% of established PsA patients and in 28% of healthy volunteers. The lateral epicondyle and the quadriceps tendon were affected in one-third of the entheses in patients (Table 2) . In healthy volunteers, one-third of the quadriceps entheses and distal patellar entheses showed a PD signal.
MASEI
The median MASEI score with the lateral epicondyle added was 18 (IQR 15-31) in new with PsA, 22 (IQR 15-27) in established PsA, and 10 (IQR 5-15) in healthy volunteers (p = 0.002). As described before, the main contributors to the MASEI scores in healthy volunteers were increased thickness and PD signal in knee entheses. After we excluded knee entheseal thickness and used the new PD scores, the IQRs were no longer overlapping. The scores of the modified MASEI were 13 (IQR 10-22.5), 13.5 (IQR 9.5-18), and 3 (IQR 1-8.5, p = 0.002) ( Table 3) .
Discussion
Sonographic changes in the entheses were observed in young, healthy volunteers, patients with recently diagnosed PsA, and patients with established PsA. Increased thickness and a subtle positive PD signal in knee entheses were common in healthy volunteers and patients, while abnormalities at other locations predominantly occurred in patients. After we excluded patellar tendon enthesis thickness and applied a new method of scoring PD, the modified MASEI was able to distinguish between PsA patients and healthy controls. Furthermore, A  B  C  A  B  C  A  B  C  A  B  C  A  B  C  A  B  C   Lateral epicondyle tendon  4  80  74  20  2  56  28  8  36  34  Triceps tendon  2  2  16  14  2  6  4  16  22  2  10  Quadriceps tendon  2  8  2  66  56  50  2  68  50  30  28  30  34  Proximal patella tendon  4  52  60  58  2  22  12  6  8  12  2  Distal patella tendon  12  82  74  70  2  18  16  16  14  30  Achilles tendon  8  26  4  8  4  70  56  8  8  10  2  8  6  Plantar fascia  24  28  4  16  2  6 Data are shown as the number of abnormalities (%) per group. PD, power Doppler; A, new psoriatic arthritis patients; B, established psoriatic arthritis patients; C, healthy volunteers. *Calcification is expressed as the number of tendons with a score > 0. we showed that ultrasound abnormalities are already very common in early PsA. The extreme contrast we expected between young healthy volunteers and PsA was not reflected in the MASEI score. We chose to compare PsA patients and clearly non-diseased young subjects, expecting a big contrast owing to differences in disease status and age. Tendon thickness reference values explained part of the overlap, especially in the case of the knee entheses. The reference values originate from an ultrasound study of human cadaveric limbs aged 67-87 years (10) and probably underestimate enthesis thickness. Small spots of PD signal in healthy volunteers further diminished the expected extreme contrast. Our findings seem to suggest that a single spot of PD is not of value in identifying active entheseal inflammation and that at least a confluent signal is necessary. Furthermore, the patellar tendon is susceptible to showing hypervascularity after acute physical stress. A study performing PD examination on runners showed hypervascularity in the patellar tendon directly after a marathon (11) .
Our results raise questions and challenges for the future. First, our controls were not age matched. Therefore, the differences between controls and patients cannot solely be ascribed to entheseal inflammation due to PsA. The effect of ageing is likely to play a role as well, which is also reflected in higher scores in the slightly older new PsA group. The effect of factors such as obesity, physical exercise, age, and gender could not be analysed, as the subgroups would be too small to analyse. Secondly, compared to other studies in early PsA, we found slightly higher scores on PD, possibly due to differences in study design and the machines used (12, 13) .
Conclusion
Ultrasound structural changes and inflammation in the enthesis were common in both new and established PsA patients, and in the knees of healthy young adults, using the MASEI score. Excluding knee entheses thickness and refinement of PD signal scores provided discrimination of PsA from healthy young volunteers in terms of enthesis pathology.
